AirSculpt Technologies, Inc. (AIRS)

AirSculpt Technologies, Inc. (AIRS) — VMCI valuation read

Composite valuation read on AIRS: VMCI 35/100 against a Healthcare sector median of 50. The 15-point below-median print is the headline number for AirSculpt Technologies, Inc., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.

Trailing 30-day insider activity for AIRS: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.

**Investor frame.** Value, quality, risk in three lines on AIRS: AIRS trades at 25.0x earnings, 39% above the Healthcare median of 18.0x; ROIC of 17.0% sits 7.0pp above the Healthcare median (10.0%); net debt to EBITDA of -0.5x leaves covenant headroom. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.

AIRS rose 1.4% over the trailing 7 days, with a +4.3% read on a 30-day basis.